Dashboard
High Management Efficiency with a high ROCE of 17.96%
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.83 times
Poor long term growth as Operating profit has grown by an annual rate 4.78% of over the last 5 years
Negative results in Jun 25
With ROCE of 13.18%, it has a expensive valuation with a 3.37 Enterprise value to Capital Employed
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Industrial Manufacturing
USD 14,647 Million (Small Cap)
32.00
NA
144.52%
0.33
12.34%
3.65
Total Returns (Price + Dividend) 
IDEX Corp. for the last several years.
Risk Adjusted Returns v/s 
News
Is IDEX Corp. overvalued or undervalued?
As of 17 October 2025, the valuation grade for IDEX Corp. has moved from fair to expensive, indicating a shift towards overvaluation. The company is currently assessed as overvalued based on its P/E ratio of 32, which is significantly higher than the peer average of 29.59, and an EV to EBITDA ratio of 20.22 compared to the peer average of 17.87. Additionally, the Price to Book Value stands at 4.20, further supporting the notion of overvaluation in the context of its industry. In terms of peer comparison, IDEX Corp. shows a higher P/E and EV to EBITDA ratio than its peers, suggesting that investors are paying a premium for its earnings relative to similar companies. Notably, the company's recent performance has been underwhelming, with a year-to-date return of -20.54%, contrasting sharply with the S&P 500's return of 13.30% over the same period, which reinforces the perception of overvaluation....
Read More
IDEX Corp. Experiences Valuation Adjustment Amidst Mixed Financial Performance Indicators
IDEX Corp. has recently adjusted its valuation, with its stock price at $166.31. The company has seen a -20.76% return over the past year, underperforming the S&P 500. Key metrics include a P/E ratio of 32, an EV to EBITDA ratio of 20.22, and a strong dividend yield.
Read MoreIs IDEX Corp. overvalued or undervalued?
As of 17 October 2025, the valuation grade for IDEX Corp. has moved from fair to expensive, indicating that the stock is overvalued. The company exhibits a P/E ratio of 32, significantly higher than its peer average of 29.59, and a Price to Book Value of 4.20, which also suggests a premium valuation compared to industry standards. Additionally, the EV to EBITDA ratio stands at 20.22, further reinforcing the perception of overvaluation. In comparison to peers, IDEX Corp.'s valuation ratios highlight its expensive positioning within the industrial manufacturing sector. Notably, while IDEX Corp. has a robust dividend yield of 128.14%, its return on equity (ROE) of 12.96% and return on capital employed (ROCE) of 13.18% do not justify the high valuation multiples. Furthermore, the stock has underperformed against the S&P 500 over various periods, with a year-to-date return of -20.54% compared to the index's 13....
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 145 Schemes (51.53%)
Held by 335 Foreign Institutions (32.34%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 6.28% vs -5.63% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 37.42% vs -22.56% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -0.16% vs 2.89% in Dec 2023
YoY Growth in year ended Dec 2024 is -15.28% vs 1.52% in Dec 2023






